A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)

Clinical trial NCT04913220 · TERMINATED

Trial details

NCT number: NCT04913220
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma Squamous Cell Carcinoma of Skin

Start date: 2021-07-15
Primary completion: 2023-08-22
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.